The GBS│CIDP Foundation International is working for a future when no one with Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and related syndromes such as multifocal motor neuropathy (MMN) suffers alone and that everyone has access to the right diagnosis and the right treatment, right away.

Our commitment is our story. It all began with eight people sitting around a dining room table 30 years ago. Through the hard work and determination of our Founder, Estelle Benson, the Foundation grew larger and has become able to support thousands of patients, family members, friends, and caregivers. The Foundation is committed to providing the experience of care and support that is indicative of the original grassroots mission.

Our commitment is to support those touched by GBS | CIDP, and variants so that every patient has access to an early and accurate diagnosis, proper treatment, and the opportunity for a full recovery. Learn about our Founders, Bob and Estelle Benson, and the fascinating historic journey that was once 8 and is now over 30,000 members! Our Leadership, guided by our Board of Directors, is committed to success in all areas of support, education, research, and advocacy. The Foundation is extremely fortunate to be associated with the top experts in neurology. This expertise extends to you in many ways, including the Centers of Excellence programs which provide first-class care to GBS-CIDP patients.

Funds raised through our walk program will help to support our research initiatives including:

Diagnosis – Developing methods to more rapidly diagnose GBS, CIDP, and its variants, such as MMN.
Treatments – Developing more effective treatments to limit disease progression, prevent complications, and reduce long-term adversities.

Biomarkers – Identifying potential disease activity biomarkers by screening for proteins related to the nervous system and inflammation.

2024 Walk & Roll

Seattle

About Seattle

*BE SURE TO ATTEND THE EVENT TO RECEIVE YOUR COMPLIMENTARY GIFT(S)